Intraatrial reentrant tachycardias in patients after atrial switch procedures for d-transposition of the great arteries - Endocardial mapping and radiofrequency catheter ablation primarily targeting protected areas of atrial tissue within the systemic venous atrium
Abstrakt
Thirteen patients with d-transposition of the great arteries after the Mustard/Senning procedure underwent electrophysiological study for recurrent intraatrial reentrant tachycardia (IARTs). In 8 patients, a 20-pole electrode catheter and a steerable 7F mapping and ablation catheter were placed in the systemic venous atrium, and via the retrograde route in the pulmonary venous atrium, if required.
During IART pace mapping and entrainment mapping were performed in order to localize protected areas of atrial tissue between anatomical and/or surgical barriers of electrical isolation. The systemic venous atrium of 5 patients was studied using the non-contact mapping system (Ensite 3000(TM)).
Linear radiofrequency current lesions were induced after mapping of electrical protected areas from the medial aspect of the superior caval vein to the systemic venous atrium and/or intraatrial baffle or the intraatrial suture line in 4 patients, from the medial aspect of mitral valve annulus to the inferior caval vein in 5 patients, from the intraatrial suture line to the posterior systemic venous atrium in 1 patient and in 2 patients from the posterior and inferior pulmonary venous atrium to the tricuspid valve annulus. Subsequently, 14 of the 15 identified IARTs were not inducible during repeated programmed stimulation.
Mean duration of the electrophysiological study was 202 min, mean fluoroscopy time was 21.6 min. During follow-up (mean 20 months), 10 of 12 patients with successful procedures are free of tachycardia, 2 patients developed IARTs with a new morphology.
In the majority of our patients, curative treatment was feasible by induction of linear radiofrequency current lesions by primarily targeting electrical protected areas of atrial tissue in the systemic venous atrium.